The Rest Is Money

2. The drug behind Europe's most valuable company

How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discovery of the century?

Join Robert and Steph as they answer all these questions and more on today's episode of The Rest Is Money.
Learn more about your ad choices. Visit podcastchoices.com/adchoices

Robert Peston and Steph McGovern follow the money to bring you insightful stories from the world of business and finance. 

Who’s making money and who’s spending it? Who’s investing, and who’s innovating? How will AI affect the way we work and why are Saudi Arabia buying up sport? How can the UK economy recover its productivity and adapt for the future?

Steph and Robert tap their extensive business contacts to answer these questions and decode the jargon to help make sense of the financial world.